By submitting this form, you are consenting to receive marketing emails from: Sickle Cell Disease Association of America, 3700 Koppers Street, Suite 570, Baltimore, MD, 21227, US, http://sicklecelldisease.org. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact.
Sickle Cell News
- SCDAA Releases Comments on the CDC’s Opioid Guidelines May 16, 2022
- In Memory of Dr. Kwaku Ohene-Frempong May 10, 2022
- SCDAA recognized for leadership May 6, 2022
- MARAC Advisory: COVID-19 and Sickle Cell Disease March 17, 2022
- SCDAA partners with Phi Beta Sigma Fraternity March 17, 2022